Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
McKesson
Baxter
Harvard Business School

Last Updated: October 1, 2022

Investigational Drug Information for Amyl Nitrite


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Amyl Nitrite?

Amyl Nitrite is an investigational drug.

There have been 3 clinical trials for Amyl Nitrite. The most recent clinical trial was a Phase 3 trial, which was initiated on December 21st 2021.

The most common disease conditions in clinical trials are Esophageal Achalasia, Poisoning, and Ventricular Outflow Obstruction. The leading clinical trial sponsors are Johns Hopkins University, Alan H. Tieu, MD, and Mayo Clinic.

Recent Clinical Trials for Amyl Nitrite
TitleSponsorPhase
Phase 1 Study of SIAN Nasal Spray in Healthy AdultsDepartment of Health and Human ServicesPhase 1
Phase 1 Study of SIAN Nasal Spray in Healthy AdultsEmergent BioSolutionsPhase 1
Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic CardiomyopathyMayo ClinicN/A

See all Amyl Nitrite clinical trials

Clinical Trial Summary for Amyl Nitrite

Top disease conditions for Amyl Nitrite
Top clinical trial sponsors for Amyl Nitrite

See all Amyl Nitrite clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
McKesson
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.